Verition Fund Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,427
| Closed | -$351K | – | 2489 |
|
2022
Q3 | $351K | Buy |
1,427
+440
| +45% | +$108K | ﹤0.01% | 1647 |
|
2022
Q2 | $244K | Buy |
+987
| New | +$244K | ﹤0.01% | 1760 |
|
2021
Q4 | – | Sell |
-772
| Closed | -$251K | – | 2246 |
|
2021
Q3 | $251K | Buy |
+772
| New | +$251K | ﹤0.01% | 1278 |
|
2020
Q3 | – | Sell |
-1,365
| Closed | -$330K | – | 1355 |
|
2020
Q2 | $330K | Buy |
+1,365
| New | +$330K | 0.01% | 696 |
|
2020
Q1 | – | Sell |
-1,843
| Closed | -$314K | – | 1036 |
|
2019
Q4 | $314K | Buy |
1,843
+286
| +18% | +$48.7K | 0.01% | 695 |
|
2019
Q3 | $277K | Buy |
+1,557
| New | +$277K | 0.01% | 712 |
|
2019
Q2 | – | Sell |
-2,707
| Closed | -$773K | – | 1344 |
|
2019
Q1 | $773K | Buy |
+2,707
| New | +$773K | 0.03% | 444 |
|
2018
Q3 | – | Sell |
-1,245
| Closed | -$509K | – | 1395 |
|
2018
Q2 | $509K | Sell |
1,245
-4,581
| -79% | -$1.87M | 0.03% | 621 |
|
2018
Q1 | $1.7M | Buy |
+5,826
| New | +$1.7M | 0.13% | 170 |
|
2017
Q3 | – | Sell |
-2,246
| Closed | -$322K | – | 1360 |
|
2017
Q2 | $322K | Buy |
+2,246
| New | +$322K | 0.03% | 590 |
|
2016
Q3 | – | Sell |
-3,954
| Closed | -$432K | – | 1250 |
|
2016
Q2 | $432K | Buy |
+3,954
| New | +$432K | 0.06% | 382 |
|